Page last updated: 2024-08-23

alovudine and Paraganglioma

alovudine has been researched along with Paraganglioma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Millo, C; Pacak, K1
Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Merino, M; Millo, C; Pacak, K; Taieb, D1

Other Studies

2 other study(ies) available for alovudine and Paraganglioma

ArticleYear
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:12

    Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radioactive Tracers

2013
18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:12

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Cell Proliferation; Dideoxynucleosides; Dopamine; Female; Genetic Testing; Glycolysis; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reference Standards; Risk Factors; Whole Body Imaging

2015